Minimal change disease cost-effectiveness of therapy: Difference between revisions
Jump to navigation
Jump to search
m Robot: Changing Category:Diseases to Category:Disease |
|||
| Line 1: | Line 1: | ||
== Overview == | |||
[[Azathioprine]] may be cost effective in treating the patients with [[minimal change disease]] . | |||
== Cost-effectiveness of Therapy == | |||
* [[Azathioprine]] therapy may used in [[glucocorticoid]]-resistant disease with the patients of [[minimal change disease]].<ref name="pmid3747335">{{cite journal |vauthors=Nolasco F, Cameron JS, Heywood EF, Hicks J, Ogg C, Williams DG |title=Adult-onset minimal change nephrotic syndrome: a long-term follow-up |journal=Kidney Int. |volume=29 |issue=6 |pages=1215–23 |date=June 1986 |pmid=3747335 |doi= |url=}}</ref> | |||
* [[Azathioprine]] is cost effective and may be as effective and less costly than MMF for this indication. | |||
__NOTOC__ | __NOTOC__ | ||
{{Minimal change disease}} | {{Minimal change disease}} | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Latest revision as of 20:14, 11 June 2018
Overview
Azathioprine may be cost effective in treating the patients with minimal change disease .
Cost-effectiveness of Therapy
- Azathioprine therapy may used in glucocorticoid-resistant disease with the patients of minimal change disease.[1]
- Azathioprine is cost effective and may be as effective and less costly than MMF for this indication.
|
Minimal Change Disease Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Minimal change disease cost-effectiveness of therapy On the Web |
|
American Roentgen Ray Society Images of Minimal change disease cost-effectiveness of therapy |
|
Minimal change disease cost-effectiveness of therapy in the news |
|
Blogs on Minimal change disease cost-effectiveness of therapy |
|
Risk calculators and risk factors for Minimal change disease cost-effectiveness of therapy |